Naltrexone
Naltrexone

6.72
For patients managing addiction and withdrawal, this generic medicine blocks opioid receptors to reduce cravings and decrease the reward sensation associated with substance use.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Naltrexone hydrochloride
Reference Brand
Revia
Product Origin
Generic Product
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Hormones
Product Category
Opioid Receptor Antagonist
Pharmacological Class
Opioid and Alcohol Antagonist
Clinical Indications
Manufacturer Description
Formulated to alleviate alcohol and opioid cravings to support long-term abstinence and target neurological recovery.
Mechanism of Action
Blocks endogenous opioid receptors, lowering the reward signaling associated with alcohol and opioid consumption.
Route of Administration
Oral
Onset Time
1 hour
Duration
24–72 hours
Contraindications
Acute hepatitis, Liver failure, Active opioid analgesic therapy
Severe Adverse Events
Severe hepatotoxicity — requires immediate medical attention
Common Side Effects
Nausea, Headache, Dizziness
Uncommon Side Effects
Insomnia, Anxiety, Abdominal pain
Drug Interactions
Opioid Analgesics
Pregnancy Safety Warnings
TGA Category C: Use if potential benefit outweighs risk. Breastfeeding: Consult a doctor.
Age Restrictions
Approved for adults over eighteen years.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Naltrexone is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to purchase Menopause Treatment Australia - Raloxifene SERM Menopause Osteoporosis